RT Journal Article
SR Electronic
T1 Refined Matrix Completion for Spectrum Estimation of Heart Rate Variability
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.30.22281728
DO 10.1101/2022.10.30.22281728
A1 Lu, Lei
A1 Zhu, Tingting
A1 Tan, Ying
A1 Zhou, Jiandong
A1 Clifton, Lei
A1 Zhang, Yuan-Ting
A1 Clifton, David A.
YR 2022
UL http://medrxiv.org/content/early/2022/11/03/2022.10.30.22281728.abstract
AB Heart rate variability (HRV) is the reflection of physiological effects modulating heart rhythm. In particular, spectral HRV metrics provide valuable information to investigate activities of the cardiac autonomic nervous system. However, uncertainties and artifacts from measurements can reduce signal quality and therefore affect the evaluation of HRV measures. In this paper, we propose a new method for HRV spectrum estimation with measurement uncertainties using matrix completion (MC). We show that missing values of HRV spectrum can be efficiently estimated using the MC method by leveraging the low rank property of the spectrum matrix. In addition, we proposed a refined matrix completion (RMC) method to improve the estimation accuracy and computational efficiency by introducing model information for the HRV spectrum. Experimental studies on five public benchmark datasets show the effectiveness and robustness of the developed RMC method for estimating missing entries for HRV spectrum with different masking ratios. Furthermore, our developed RMC method is compared with five deep learning models and the traditional MC method; the results of this comparison study demonstrate that our developed RMC method obtains the least estimation error with the minimal computation cost, indicating the advantages of our developed method for HRV spectrum estimation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), and in part by an InnoHK Project at the Hong Kong Centre for Cerebro cardiovascular Health Engineering (COCHE). D. A. Clifton is an Investigator in the Pandemic Sciences Institute, University of Oxford, Oxford, UK. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, InnoHK ITC, or the University of Oxford. L. Lu is supported fully by InnoHK Project on Project 1.1 Wearable Intelligent Sensing Engineering (WISE) at Hong Kong Centre for Cerebro cardiovascular Health Engineering (COCHE).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used (or will use) ONLY openly available human data that were originally located at PhysioNet, https://physionet.org/about/database/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://physionet.org/about/database/